Outlook Therapeutics Inc (OTLK)

[H2R]

Nope, just digesting the info.

1) The Company did not provide a 'clean' submission to the FDA. I'm not super happy with that.
2) The Company has kept their timeline in the past, quite well actually. So their assessment of a September 2022 is a little reassuring.

I was expecting the FDA to provide a PDUFA date. Instead, it's back to the submission step. So not great, but the value is still there. The risk now is that the submission will be marred before even making it to PDUFA. I don't think that will be the case.

As for me, I did not sell any shares. I'm more in 'hold' mode at this point.

Best of luck with your investments!